Condensed Consolidated Statements of Cash Flows (USD $)	12 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Cash flows from operating activities
Net loss	$ (12,452,642)	$ (13,920,940)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation of property, plant and equipment	798,424	929,776
Amortization of intangible assets	732,049	745,385
Stock-based compensation	785,260	1,586,798
Equity in loss of investee company	779,768	197,618
Payment of interest with common stock		66,500
Amortization of discounts and debt issuance costs on notes payable	14,566	1,069,950
Non-cash expense attributed to accretion of note payable	45,000
Changes in assets and liabilities
Accounts receivable	33,638	(308,941)
Inventories	96,445	(1,326,357)
Prepaids and other current assets	(51,660)	(130,986)
Refundable income taxes	48,317	(20,905)
Accounts payable	(1,328,097)	937,808
Accrued compensation and benefits	(170,932)	45,373
Accrued expenses	(467,475)	618,026
Customer deposits	878,953	(213,173)
Net cash used in operating activities	(10,258,386)	(9,724,068)
Cash flows from investing activities
Expenditures for property and equipment	(137,601)	(1,647,450)
Investment in investee company		(3,281,507)
Deposits of restricted cash		(60,000)
Net cash used in investing activities	(137,601)	(4,988,957)
Cash flows from financing activities
Proceeds from issuance of notes payable	938,250	2,465,000
Repayments of bank loans and notes payable	(1,654,593)	(3,243,184)
Notes payable issuance costs	(29,113)	(227,693)
Proceeds from issuance of Series A preferred stock		2,197,240
Proceeds from issuance of common stock	4,648,499	17,138,150
Common stock issuance costs	(177,607)	(1,810,598)
Proceeds from noncontrolling interest	5,500	3,083,062
Net cash provided by financing activities	3,730,936	19,601,977
Effect of exchange rate changes on cash and cash equivalents	(1,545)	(36,330)
Net increase (decrease) in cash and cash equivalents	(6,666,596)	4,852,622
Cash and cash equivalents - beginning of period	7,763,217	2,910,595
Cash and cash equivalents - end of period	1,096,621	7,763,217
Cash paid for interest	173,876	278,610
Cash received for income tax credit	198,309	223,703
Supplemental non-cash investing and financing activities:
Conversion of debenture notes payable to common stock		1,184,250
Inventory transferred to assets held for lease	355,986
Interest deferred and added to principal balance of note payable	44,084
Issuance of common stock for discounted notes receivable		2,187,330
Issuance of warrants as consideration for equity issuance costs		1,024,726
Redemption of preferred stock with notes receivable - common stock		$ 6,436,089